Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | CES1 | P23141 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12380748 | 1.00 | MEN1 (0.47) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL723723 | 0.91 | TSHR (0.44) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1142832 | 0.87 | DGKA (0.48) | MEN1KMT2ADGKATSHRALDH1A1 | |
| SCHEMBL1142293 | 0.87 | DGKA (0.48) | MEN1KMT2ADGKATSHRALDH1A1 | |
| SCHEMBL1142380 | 0.87 | DGKA (0.48) | MEN1KMT2ADGKATSHRALDH1A1 | |
| SCHEMBL1142604 | 0.87 | TSHR (0.48) | DGKATSHRALDH1A1CES2CES1 | |
| SCHEMBL1142331 | 0.87 | TSHR (0.48) | DGKATSHRALDH1A1CES2CES1 | |
| SCHEMBL9680030 | 0.87 | TSHR (0.53) | DGKATSHRCES2CES1 | |
| SCHEMBL1142903 | 0.87 | DGKA (0.48) | MEN1KMT2ADGKATSHRALDH1A1 | |
| SCHEMBL1142743 | 0.87 | TSHR (0.48) | DGKATSHRALDH1A1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080003245-A1 | Use of octyl salicylate in cosmetic preparations containing 1,3-dihydroxyacetone | BEIERSDORF AG (DE) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080003245-A1 | Use of octyl salicylate in cosmetic preparations containing 1,3-dihydroxyacetone | ALDH1A1, ALDH3A1, ALDH1A3 | MEN1 3724/4885KMT2A 2664/4885THRB 3459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.